Cancer

Caris Life Sciences Publishes Study Showing AI Signature-positive Breast Cancer Patients Live Almost Twice as Long as AI-negative Patients When Treated with a Checkpoint Inhibitor

Groundbreaking study in Communications Medicine highlights AI's role in transforming immunotherapy decisions and precision oncology IRVING, Texas, Aug. 6, 2025…

5 months ago

MyHealthTeam Now Hosts 11 Communities for People Living with Cancer

MyBladderCancerTeam and MyEndometrialCancer Team connect oncology patients with medically reviewed online content and support SAN FRANCISCO, Aug. 6, 2025 /PRNewswire/…

5 months ago

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis

Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring…

5 months ago

From AI to Precision Medicine: Taiwan’s Smart Healthcare Innovations Shine at Taiwan Expo USA 2025

DALLAS, Aug. 5, 2025 /PRNewswire/ -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the…

5 months ago

13 Women-Led Tech Startups Join FourthWave’s 2025 Accelerator Program

Thirteen women-led tech startups have been selected to participate in FourthWave's 16-week 2025 accelerator program that provides founders with one-on-one…

5 months ago

CTS provides Connectivity to Memorial Sloan Kettering Cancer Center with State-of-the-Art Distributed Antenna System

New DAS will improve patient care, visitor convenience and operational efficiency MARLBOROUGH, Mass., Aug. 5, 2025 /PRNewswire/ -- Communication Technology…

5 months ago

Yonsei University Researchers Develop Deep Learning Model for Microsatellite Instability-High Tumor Prediction

The proposed model achieves high accuracy for ICI responsiveness prediction as well by combining tumor MSI status with stroma-to-tumor ratio…

5 months ago

VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers

Multi-disciplinary cancer center joins VieCure's intelligent care ecosystem, bringing advanced precision oncology capabilities to the Pacific Northwest DENVER, CO /…

5 months ago

Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in…

5 months ago

Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia

Continued progress positions Company to report topline data for Phase 1 clinical trial of SENTI-202 before year-endSOUTH SAN FRANCISCO, Calif.,…

5 months ago